Fluoxetine
What it is
We have not added a short description yet.
Why it is on this page
People: source-defined study populations
DailyMed fluoxetine hydrochloride label · checked Sep 19, 2026
Relationship: label-reported clinical studies for the Need
Scope: country:US
Pointer: /sections/4
Supporting passage: The efficacy of fluoxetine was studied in 5- and 6-week placebo-controlled trials with depressed adult and geriatric outpatients (≥ 18 years of age) whose diagnoses corresponded most closely to the DSM-III (currently DSM-IV) category of MDD.
Open sourceSource: DailyMed fluoxetine hydrochloride label. Checked Sep 19, 2026. Scope: country:US. Link: https://dailymed.nlm.nih.gov/dailymed/services/v2/spls/f274f102-67ec-46e7-b248-533be2e3003b.xml
Research for Major Depressive Disorder
Research suggests benefit in this exact scope
Published Sep 20, 2026 · revision 1
conclusion
The retained fluoxetine label reports placebo-controlled studies for major depressive disorder; this assessment does not determine personal suitability or compare fluoxetine with every alternative.
DailyMed fluoxetine hydrochloride label · checked Sep 19, 2026
Relationship: supports bounded conclusion
Scope: country:US
Pointer: /sections/4
Supporting passage: The efficacy of fluoxetine was studied in 5- and 6-week placebo-controlled trials with depressed adult and geriatric outpatients (≥ 18 years of age) whose diagnoses corresponded most closely to the DSM-III (currently DSM-IV) category of MDD.
Open sourceSource: DailyMed fluoxetine hydrochloride label. Checked Sep 19, 2026. Scope: country:US. Link: https://dailymed.nlm.nih.gov/dailymed/services/v2/spls/f274f102-67ec-46e7-b248-533be2e3003b.xml
Compared with the others: Not directly compared. We show each option’s own research.